BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 15631256)

  • 1. The Texas medication algorithm project: clinical results for schizophrenia.
    Miller AL; Crismon ML; Rush AJ; Chiles J; Kashner TM; Toprac M; Carmody T; Biggs M; Shores-Wilson K; Chiles J; Witte B; Bow-Thomas C; Velligan DI; Trivedi M; Suppes T; Shon S
    Schizophr Bull; 2004; 30(3):627-47. PubMed ID: 15631256
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Texas Medication Algorithm Project, phase 3 (TMAP-3): clinical results for patients with a history of mania.
    Suppes T; Rush AJ; Dennehy EB; Crismon ML; Kashner TM; Toprac MG; Carmody TJ; Brown ES; Biggs MM; Shores-Wilson K; Witte BP; Trivedi MH; Miller AL; Altshuler KZ; Shon SP;
    J Clin Psychiatry; 2003 Apr; 64(4):370-82. PubMed ID: 12716236
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Texas Medication Algorithm Project, phase 3 (TMAP-3): rationale and study design.
    Rush AJ; Crismon ML; Kashner TM; Toprac MG; Carmody TJ; Trivedi MH; Suppes T; Miller AL; Biggs MM; Shores-Wilson K; Witte BP; Shon SP; Rago WV; Altshuler KZ;
    J Clin Psychiatry; 2003 Apr; 64(4):357-69. PubMed ID: 12716235
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical results for patients with major depressive disorder in the Texas Medication Algorithm Project.
    Trivedi MH; Rush AJ; Crismon ML; Kashner TM; Toprac MG; Carmody TJ; Key T; Biggs MM; Shores-Wilson K; Witte B; Suppes T; Miller AL; Altshuler KZ; Shon SP
    Arch Gen Psychiatry; 2004 Jul; 61(7):669-80. PubMed ID: 15237079
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Texas Medication Algorithm Project: development and feasibility testing of a treatment algorithm for patients with bipolar disorder.
    Suppes T; Swann AC; Dennehy EB; Habermacher ED; Mason M; Crismon ML; Toprac MG; Rush AJ; Shon SP; Altshuler KZ
    J Clin Psychiatry; 2001 Jun; 62(6):439-47. PubMed ID: 11465521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. How Effective Is Algorithm-Guided Treatment for Depressed Inpatients? Results from the Randomized Controlled Multicenter German Algorithm Project 3 Trial.
    Adli M; Wiethoff K; Baghai TC; Fisher R; Seemüller F; Laakmann G; Brieger P; Cordes J; Malevani J; Laux G; Hauth I; Möller HJ; Kronmüller KT; Smolka MN; Schlattmann P; Berger M; Ricken R; Stamm TJ; Heinz A; Bauer M
    Int J Neuropsychopharmacol; 2017 Sep; 20(9):721-730. PubMed ID: 28645191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Texas Medication Algorithm Project antipsychotic algorithm for schizophrenia: 2003 update.
    Miller A; Hall CS; Buchanan RW; Buckley PF; Chiles JA; Conley RR; Crismon ML; Ereshefsky L; Essock SM; Finnerty M; Marder SR; Miller DD; McEvoy JP; Rush AJ; Saeed SA; Schooler NR; Shon SP; Stroup S; Tarin-Godoy B
    J Clin Psychiatry; 2004 Apr; 65(4):500-8. PubMed ID: 15119912
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Texas Medication Algorithm Project (TMAP) schizophrenia algorithms.
    Miller AL; Chiles JA; Chiles JK; Crismon ML; Rush AJ; Shon SP
    J Clin Psychiatry; 1999 Oct; 60(10):649-57. PubMed ID: 10549680
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A feasibility study of the childhood depression medication algorithm: the Texas Children's Medication Algorithm Project (CMAP).
    Emslie GJ; Hughes CW; Crismon ML; Lopez M; Pliszka S; Toprac MG; Boemer C;
    J Am Acad Child Adolesc Psychiatry; 2004 May; 43(5):519-27. PubMed ID: 15100558
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Texas Medication Algorithm Project: definitions, rationale, and methods to develop medication algorithms.
    Gilbert DA; Altshuler KZ; Rago WV; Shon SP; Crismon ML; Toprac MG; Rush AJ
    J Clin Psychiatry; 1998 Jul; 59(7):345-51. PubMed ID: 9714262
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An empirical analysis of cost outcomes of the Texas Medication Algorithm Project.
    Kashner TM; Rush AJ; Crismon ML; Toprac M; Carmody TJ; Miller AL; Trivedi MH; Wicker A; Suppes T
    Psychiatr Serv; 2006 May; 57(5):648-59. PubMed ID: 16675759
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Implementation of the Texas Medication Algorithm Project patient and family education program.
    Toprac MG; Dennehy EB; Carmody TJ; Crismon ML; Miller AL; Trivedi MH; Suppes T; Rush AJ
    J Clin Psychiatry; 2006 Sep; 67(9):1362-72. PubMed ID: 17017822
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mental health care from the public perspective: the Texas Medication Algorithm Project.
    Shon SP; Crismon ML; Toprac MG; Trivedi M; Miller AL; Suppes T; Rush AJ
    J Clin Psychiatry; 1999; 60 Suppl 3():16-20; discussion 21. PubMed ID: 10073372
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A standardized stepwise drug treatment algorithm for depression reduces direct treatment costs in depressed inpatients - Results from the German Algorithm Project (GAP3).
    Ricken R; Wiethoff K; Reinhold T; Stamm TJ; Baghai TC; Fisher R; Seemüller F; Brieger P; Cordes J; Laux G; Hauth I; Möller HJ; Heinz A; Bauer M; Adli M
    J Affect Disord; 2018 Mar; 228():173-177. PubMed ID: 29253683
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Attitudes Toward Medications and the Relationship to Outcomes in Patients with Schizophrenia.
    Campbell AH; Scalo JF; Crismon ML; Barner JC; Argo TR; Lawson KA; Miller A
    Clin Schizophr Relat Psychoses; 2018; 12(1):12-22. PubMed ID: 26218237
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Texas Medication Algorithm Project: development and implementation of the schizophrenia algorithm.
    Chiles JA; Miller AL; Crismon ML; Rush AJ; Krasnoff AS; Shon SS
    Psychiatr Serv; 1999 Jan; 50(1):69-74. PubMed ID: 9890582
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A meta-analysis and critical review of the effects of conventional neuroleptic treatment on cognition in schizophrenia: opening a closed book.
    Mishara AL; Goldberg TE
    Biol Psychiatry; 2004 May; 55(10):1013-22. PubMed ID: 15121486
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurocognitive effects of ziprasidone and related factors in patients with chronic schizophrenia undergoing usual care: a 12-month, open-label, flexible-dose, naturalistic observational trial.
    Gibel A; Ritsner MS
    Clin Neuropharmacol; 2008; 31(4):204-20. PubMed ID: 18670244
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A double-blind study of combination of clozapine with risperidone in patients with schizophrenia: effects on cognition.
    Akdede BB; Anil Yağcioğlu AE; Alptekin K; Turgut TI; Tümüklü M; Yazici MK; Jayathilake K; Tunca Z; Göğüş A; Meltzer HY
    J Clin Psychiatry; 2006 Dec; 67(12):1912-9. PubMed ID: 17194269
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Texas Medication Algorithm Project Patient and Family Education Program: a consumer-guided initiative.
    Toprac MG; Rush AJ; Conner TM; Crismon ML; Dees M; Hopkins C; Rowe V; Shon SP
    J Clin Psychiatry; 2000 Jul; 61(7):477-86. PubMed ID: 10937605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.